News

Sapient Capital Expands Team with David Larado's Expertise

Sapient Capital Expands Team with David Larado's Expertise

Sapient Capital Welcomes David Larado as New Partner

Industry Veteran Joins Independent RIA's New York Office, Recruiting Wealth Advisors Who Want to be Part of an Organization Built for Serving UHNW Clients

NEW YORK / -- Sapient Capital, an independent wealth advisory firm specializing in investment management, wealth strategy, and family office services for families and individuals in need, announces that David Larado has joined the firm as a Partner. He will lead efforts to recruit private wealth advisors across the nation. With over $23 billion in assets under management, Sapient is committed to expanding its services and team strength.

Although the firm has deep historical roots, Sapient launched as an independent Registered Investment Advisor (RIA) in 2023, aiming to deliver a tailored advisory approach for ultra-high-net-worth (UHNW) clients. This strategy is grounded in thoughtful planning, disciplined investing, and strategic advice. The firm prides itself on being primarily employee-owned, while also being supported by strategic and institutional partners.

Building Foundations for Growth

In just over two years, Sapient Capital has established a robust foundation poised for sustainable growth, featuring:

  • A seasoned team of senior wealth advisors, including names known for customizing investments and financial strategies for UHNW families.
  • A strong management team experienced in wealth and asset management, featuring a CEO with extensive knowledge across various sectors.
  • An alternative investment platform, emphasizing private equity, credit, real estate, and distressed investing spearheaded by an expert in the industry.
  • First-class family office services provided by professionals with solid backgrounds in notable financial institutions.
  • Advanced technology that gives advisors and clients insightful data and comprehensive portfolio views.

David Larado's presence will expedite Sapient's growth trajectory by attracting experienced advisors who value independence and understand the needs of UHNW clients.

"Over recent years, we have designed our platform to cater specifically to high-net-worth clients," said James Rooney, CEO of Sapient Capital. "David brings a wealth of experience and a deep understanding of the value that independence offers to both advisors and their clients."

David Larado, who joins from a long-standing career at UBS, held significant leadership positions in Advisor Recruiting and UHNW Americas. His experience is expected to significantly enhance Sapient's recruiting strategies.

A Promising Future and Unique Opportunity

Larado expressed enthusiasm for this new chapter at Sapient. He remarked, "The independent growth story at Sapient aligns perfectly with my career trajectory. With our cutting-edge solutions and experienced leadership, Sapient is sure to become the preferred choice for top advisors in the industry."

Additionally, Danny Rodriguez, Partner at Lee Equity, commented on the unique partnership opportunities within the firm, emphasizing the benefit of their scale and outstanding team serving an influential client base.

About Sapient Capital

Sapient Capital is focused on providing tailored investment management and family office services to embedded families and UHNW individuals. They take pride in their fiduciary responsibility to clients, fostering relationships founded on trust and transparency. Headquartered with offices across major U.S. cities, they are committed to maintaining high standards and providing superior service.

Media Contact:
Sarah Tremallo
JConnelly for Sapient Capital

Frequently Asked Questions

What are the main services offered by Sapient Capital?

Sapient Capital offers investment management, wealth strategy advisory, and family office services tailored for multi-generational families and UHNW individuals.

Who is David Larado and what is his role?

David Larado is a newly appointed Partner at Sapient Capital, focusing on recruiting experienced wealth advisors and enhancing the firm's growth strategy.

What is the significance of Sapient's independence?

Having independence allows Sapient to provide customized solutions and operate with a client-first mentality, which is beneficial for advisors and the clients they serve.

How has Sapient Capital grown since its founding?

Since becoming independent, Sapient has significantly expanded its advisor team, assets under management, and service offerings while maintaining a focus on UHNW clients.

What does Sapient Capital's management team look like?

Sapient's management team comprises seasoned experts with extensive background in wealth management, investment banking, and asset management, ensuring robust leadership.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

SKK Holdings Limited Announces Pricing for Share IPO Offering

Updated Category News Views 65

SKK Holdings Limited Announces Share Pricing for IPO SKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a specialized civil engineering service provider in subsurface utility works, has proudly announced the pricing of its initial public offering. The Company will offer 2,500,000 ordinary shares at a public offering price of $4.00 per share, yielding...

Continue Reading
Antelope Enterprise: Financial Performance Insights for 2024

Updated Category News Views 149

Antelope Enterprise Holdings Limited (NASDAQ: AEHL) hit the financial report stage hard back in mid-2024, flaunting numbers that tell quite the tale of both triumphs and tribulations. This company was hustling across two growing fronts: the fast-paced world of livestreaming ecommerce and the burgeoning energy sector down in Texas. Their half-year performance review...

Continue Reading
Olivier Falut Steps Into CFO Role at EUROAPI to Drive Growth

Updated Category News Views 344

Olivier Falut Joins EUROAPI as the New Chief Financial Officer EUROAPI is excited to announce the appointment of Olivier Falut as its new Chief Financial Officer, effective immediately. Olivier will be an integral member of the Executive Committee, succeeding Evelyne Nguyen. Evelyne will ensure continuity and a smooth transition within the company through her support...

Continue Reading
OPEXUS and Casepoint Join Forces for Growth and Innovation

Updated Category News Views 261

OPEXUS and Casepoint Unite for Strategic Growth In a significant development in the technology sector, OPEXUS, a frontrunner in government process management software, and Casepoint, an innovator in data discovery technology, have announced their merger. This significant move comes along with a majority investment from Thoma Bravo, a renowned software investment firm...

Continue Reading
MeiraGTx Holdings: An In-Depth Look at Future Potential

Updated Category News Views 69

MeiraGTx Holdings plc (NASDAQ:MGTX) was a clinical-stage gene therapy firm making waves back in 2024. The company announced a pivotal financial move, securing $50 million through equity financing at $4 per share, largely thanks to a $30 million investment from Sanofi (NYSE:SNY). While this funding boosted MGTX’s war chest, traders were already whispering about the heavy...

Continue Reading